Survey Data Confirms Manufacturer Priorities for 2024
Each year, the Patient Services Survey gathers insights from pharmaceutical decision-makers, healthcare providers (HCPs), and industry consultants....
It’s a surprisingly common misconception that the patient experience relating to initiating specialty treatments is straightforward once a prescription has been ordered, and once approval has been received from the payer. The truth is, the hurdles patients must overcome to access and adhere to specialty medication are numerous and ongoing.
In the following session, “The Future Hub: Data-driven, Patient-focused," I want to help manufacturers:
As discussed, CareMetx’s data-driven, patient-focused Digital Hub provides things like empathetic, educational and empowering support for patients, and one single point of contact- among other helpful foundational shifts.
The CareMetx Digital Hub also dramatically streamlines fulfillment times (between Rx and first administration) and allows clinicians to better prepare, set expectations and educate patients. This change in focus and level of service is evident to patients, who not only encounter fewer barriers, but are able to get critical help expeditiously when barriers do arise.
Each year, the Patient Services Survey gathers insights from pharmaceutical decision-makers, healthcare providers (HCPs), and industry consultants....
The success of specialty therapeutics often hinges on navigating a complex, multi-step process to initiate patients on a new therapy. Without...
The increasing complexity of specialty therapeutics and the shift toward personalized patient care calls for more advanced technological tools and...